glysophate

Both glysophate resistant, otherwise known as "Roundup Ready," they are designed to be sprayed with Roundup, Monsanto's popular weed killer.

Leslie Hatfield: Stuff My Dad Says about Monsanto - a "Roundup," If You Will 2010

Both glysophate resistant, otherwise known as "Roundup Ready," they are designed to be sprayed with Roundup, Monsanto's popular weed killer.

Stuff My Dad Says about Monsanto - a "Roundup," If You Will 2010

A combination of adverse climatic conditions in European markets during the period and price-cutting on glysophate caused by competitors seeking to drop inventory levels were the main drivers behind group sales falling $890 million to $1.24 billion during the period.

NZ On Screen 2010

Nufarm had now moved the six months 'inventory of glyphosate held at the beginning of the period into the market, and was "now purchasing glysophate acid at market competitive prices and expects to generate more acceptable margins on sales that take place in the balance of the year".

NZ On Screen 2010

"While glysophate pricing is expected to remain very competitive, Nufarm will generate acceptable margins in most markets, with the US glysophate segment still transitioning to a more normal level of profitability."

NZ On Screen 2010

A combination of adverse climatic conditions in European markets during the period and price-cutting on glysophate caused by competitors seeking to drop inventory levels were the main drivers behind group sales falling $890 million to $1.24 billion during the period.

NZ On Screen 2010

The impact of lower prices for glysophate - the generic name for the Monsanto product Round-Up, which came off-patent a decade ago - was demonstrated most dramatically in a $435 million fall in net working capital to $1.1 billion, of which $364 million was writedowns on glyphosate inventory.

NZ On Screen 2010

The impact of lower prices for glysophate - the generic name for the Monsanto product Round-Up, which came off-patent a decade ago - was demonstrated most dramatically in a $435 million fall in net working capital to $1.1 billion, of which $364 million was writedowns on glyphosate inventory.

NZ On Screen 2010

"While glysophate pricing is expected to remain very competitive, Nufarm will generate acceptable margins in most markets, with the US glysophate segment still transitioning to a more normal level of profitability."

NZ On Screen 2010

The impact of lower prices for glysophate - the generic name for the Monsanto product Round-Up, which came off-patent a decade ago - was demonstrated most dramatically in a $435 million fall in net working capital to $1.1 billion, of which $364 million was writedowns on glyphosate inventory.

NZ On Screen 2010